Monovision laser in situ keratomileusis for pre-presbyopic and presbyopic patients.
To evaluate the outcome and success of refractive surgery in pre-presbyopic and presbyopic patients with monovision after laser in situ keratomileusis (LASIK). We performed a retrospective analysis of 748 eyes of 374 patients over 35 years of age treated in one or both eyes for a monovision outcome using the Alcon LADARVision 4000 laser. Analysis of age at the time of surgery, gender, bilateral versus unilateral treatment, targeted outcome, and patient acceptance are reported. The success rate of monovision patients in this study was 92.5%. Acceptance rate was higher in older patients, although there was no significantly greater acceptance of monovision for any of the variables studied (P values >.26). Monovision is a valuable option for pre-presbyopic and presbyopic patients considering refractive surgery.